Status:
COMPLETED
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Gastric Cancer
Peritoneal Carcinomatosis
Eligibility:
All Genders
18-95 years
Brief Summary
Gastric cancer associated peritoneal carcinomatosis has a poor prognosis with a median survival of less than one year. Systemic chemotherapy including targeted agents has not been found to significant...
Eligibility Criteria
Inclusion
- Confirmed peritoneal carcinomatosis from gastric cancer
- Metachronous/synchronous peritoneal carcinomatosis
Exclusion
- \- Gastric origin of peritoneal carcinomatosis unconfirmed
Key Trial Info
Start Date :
February 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT03253939
Start Date
February 1 2017
End Date
July 1 2017
Last Update
August 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Générale et Digestive - Centre Hospitalier Lyon Sud - Hospices Civils de Lyon
Pierre-Bénite, France, 69495